Clinical Trials Sponsored by Tariq Yehia

Total 32 results

Tariq Yehia

Completed

Efficiency of Triple Antibiotic Paste, Ciprofloxacin/Propolis, Ciprofloxacin/Metronidazole, Propolis/Metronidazole Combinations on Revascularization Process of Immature Necrotic Maxillary Incisors of Patients 8-18 Years Old.

Dental Pulp Necrosis | Root Canal Infection | Periapical Abscess
Tarix Pharmaceuticals

Withdrawn

Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients Undergoing Single or Double Umbilical Cord Blood Transplantation

Hematologic Malignancy | Cord Blood Transplant | Inherited Metabolic Disease

United States
Tarix Pharmaceuticals

Terminated

Phase I Study Evaluating TXA127 in Low/Intermediate-1 Risk Myelodysplastic Syndrome and Thrombocytopenia

Myelodysplastic Syndrome (MDS)

United States
Tariq Wani

Completed

Induction Hypotension in Pediatric Population

Pediatric Surgical Patients

United States
Alaa Mohammed Yehia

Completed

Knowledge of Egyptian Dental Practitioners Regarding Molar-Incisor Hypomineralization (MIH)

Molar Incisor Hypomineralization | Dental Enamel Hypoplasia

Egypt
Tarix Pharmaceuticals

Completed

Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal Cancer

Anemia | Thrombocytopenia | Neutropenia | Lymphopenia

United States
Tarix Pharmaceuticals

Completed

Safety and Efficacy of TXA127 and Neupogen to Increase Peripheral Blood Stem Cells (PBSCs)

Miscellaneous Peripheral Blood Cell Abnormalities

United States
Tarix Pharmaceuticals

Withdrawn

Efficacy Study of a TXA127 to Reduce Acute Graft-vs-Host Disease in Subjects Undergoing Double Umbilical Cord Blood Transplantation

Hematologic Malignancies

United States
Tarix Pharmaceuticals

Withdrawn

Efficacy Study of a TXA127 to Reduce Graft-vs-Host Disease in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation

Hematologic Malignancies

United States
Dr. Tariq Alhawassi

Unknown

Inflammatory Regulation Effect of NAC on COVID-19 Treatment (INFECT-19)

COVID-19
Taris Biomedical LLC

Completed

Safety and Tolerability of GemRIS 225 mg in Subjects With Muscle-Invasive Bladder Cancer

Urinary Bladder Cancer

United States, Netherlands
Taris Biomedical LLC

Completed

Safety and Tolerability of TAR-200 mg in Subjects With Non-Muscle-Invasive Bladder Cancer

Urinary Bladder Cancer

Netherlands
Taris Biomedical LLC

Completed

Safety and Tolerability of TAR-302-5018 in Subjects With Idiopathic Overactive Bladder

Idiopathic Overactive Bladder With Urinary Incontinence

United States
Yehua Shen

Not yet recruiting

HAIC Combined With PD-L1 Plus Regorafenib in the Treatment of Advanced Hepatocellular Carcinoma After Immunotherapy Failure

HCC - Hepatocellular Carcinoma
ayesha tariq
King Edward Medical University

Recruiting

Comparison of Efficacy of Phenytoin With Levetireacetam for the Management of Children With Status Epilepticus

Status Epilepticus

Pakistan
Taris Biomedical LLC

Completed

Safety and Tolerability of TAR-302-5018 in Subjects With Neurogenic Detrusor Overactivity Resulting From Spinal Cord Injury

Neurogenic Detrusor Overactivity

United States
TARIS Biomedical, Inc.

Completed

Safety and Tolerability Study of the Taris Placebo System

Healthy

United States
Allergan
TARIS Biomedical, Inc.

Terminated

Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis

Interstitial Cystitis

United States, Canada
Allergan
TARIS Biomedical, Inc.

Completed

A Safety, Tolerability and Preliminary Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis (IC) and Hunner's Lesions

Chronic Interstitial Cystitis

United States
Allergan
TARIS Biomedical, Inc.

Terminated

Double-Blind Placebo Controlled Study of Safety,Tolerability, and Efficacy of LiRIS® in Women With Interstitial Cystitis

Interstitial Cystitis

United States, Canada
Allergan
TARIS Biomedical, Inc.

Completed

Safety Study of LiRIS in Interstitial Cystitis (IC) Patients

Interstitial Cystitis

Canada
Dr. Tarit Saha

Terminated

Functional and Anatomical MRI of the Spinal Cord and Peri-spinal Tissues

Chronic Pain | Other Functional Disturbances Following Cardiac Surgery

Canada
Dr. Tarit Saha

Completed

Does the Speed of Sternal Retraction Affect Postoperative Pain Outcomes

Chronic Pain

Canada
Tarix Pharmaceuticals
Constant Therapeutics LLC

Terminated

Acceleration of Platelet Recovery Following Autologous Peripheral Blood Stem Cell Transplant (PBSC) in Hodgkin, Non-Hodgkin Lymphoma or Multiple Myeloma Patients (TXA127-PBSC)

Lymphoma, Non-Hodgkin | Multiple Myeloma | Hodgkin Disease

United States
Tarix Pharmaceuticals
Constant Therapeutics LLC

Terminated

TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation (USBTXA127CBT)

Myelofibrosis | Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Chronic Myelocytic Leukemia | Myelodysplastic Syndrome | Acute Myelogenous Leukemia | Hodgkins Lymphoma | Non Hodgkins Lymphoma | Double Cord Blood Transplant

United States
Dina Yahia Mansour

Unknown

Intravaginal Isosorbide Mononitrate in Addition to Misoprostol Versus Misoprostol Only for Induction of Labor

Induction of Labor

Egypt
US Biotest, Inc.
Tarix Pharmaceuticals

Terminated

Safety Study of TXA127 to Elevate CD4+ T-Lymphocyte Counts in HIV-Infected Patients on Stable HAART Therapy

HIV Infections

United States
Taris Biomedical LLC
Bristol-Myers Squibb

Terminated

Safety and Tolerability of TAR-200 and Nivolumab in Subjects With Muscle-Invasive Bladder Cancer

Bladder Cancer TNM Staging Primary Tumor (T) T2 | Bladder Cancer TNM Staging Primary Tumor (T) T2A | Bladder Cancer TNM Staging Primary Tumor (T) T2B | Bladder Cancer TNM Staging Primary Tumor (T) T3 | Bladder Cancer TNM Staging Primary Tumor (T) T3A | Bladder Cancer TNM Staging Primary Tumor... and other conditions

United States
Tarik Wasfie, MD

Completed

Factors Influencing Readmission Rates of Acute Traumatic Subdural Hematoma in the Elderly

Traumatic Subdural Hematoma

United States
CathVision ApS
TRIQ GROUP Wherry & Klaffke GbR

Completed

An Evaluation of the Safety and Performance of the CathVision Cube® System

Cardiac Arrhythmia

Denmark, Czechia
Mansoura University Hospital
Azza Tarik Eliwa; Ahmed Elsayed Mansour; Taha Taha Abdelgawad; Ahmed Mohamed Fouda

Completed

Airway Inflammation, Small Airways Dysfunction, and Frequency of Exacerbations in COPD

COPD Exacerbation Acute

Egypt
Cairo University
Abdelhamid, Bassant Mohamed, M.D.; Mohamed, Ahmed A., M.D.; Ashraf Mohamed Abd... and other collaborators

Completed

The Value of Continuous Noninvasive Hemoglobin Monitoring Using Masimo Radical -7 Pulse CO-Oximeter in Intraoperative Blood Transfusion Practice During Obstetric Procedures

Masimo Radical Pulse Co-oximeter in Intraoperative Blood Transfusion Practice During Obestatric Procedure

Egypt

Clinical Trials Sponsored by Tariq Yehia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Germany

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations